John Dirks is the emeritus president and scientific director of the Gairdner Foundation.
At a time when medical science is playing the key role in treating the global COVID-19 pandemic, it is only appropriate that we celebrate the 100th birthday of molecular biologist, scientific leader and genetics pioneer Dr. Louis Siminovitch today. After all, Lou as he is affectionately known is considered by many to have had the most substantial impact on Canadian medical science in our time.
The works of English architect Christopher Wren are so prominent in London that his bequest can be found, as the famous quote goes, if you just look around you, and the same can be said of Lou in Toronto, where a constellation of notable research institutes, hospitals and networks of top scientists will speak to his legacy. And when Lou has felt Canadian science was running behind in quality or slow to engage new advances like genomics, he has energetically stepped up to the plate to forcefully challenge the political and academic powers of the day through his powerful pen lots and lots of letters to turn things around.
Story continues below advertisement
One can only stand in awe," said Henry Friesen, the founder of the Canadian Institutes of Health Research, of the profound influence Lou Siminovitch has had in inspiring so many young students, building and developing major scientific institutions, and offering decision makers wise counsel in cultivating a more robust science culture in Canada.
So how did Lou become such a respected icon? He was born in Montreal of Eastern European parents who lived near the poverty line and had little interest in learning and culture. In high school, Lou was a so-so student, surrounded by many who spent their time in leftist politics. He entered McGill with an interest in chemistry and, stimulated by a top professor, made science his career choice.
Lou embarked on a PhD in physical chemistry, graduating in 1944. He married Elinore, who typed his thesis, and they moved to Ottawa and Chalk River. There, he worked on nuclear research, meeting every day with bright scientists such as Italian physicist Bruno Pontecorvo (who later defected to the Soviet Union), kindling Lous excitement in science.
Lou has a habit of riding the ways of fortune between opportunity, despair and joy. When his interest turned to biology he likes to say that he has a high mutation rate, seeking new challenges and new fields every 10 years he met French and Canadian scientist Louis Rapkine, who invited Lou to join his lab in Paris where he became a successful experimenter. But Rapkine died suddenly, leaving Lou with no mentor and no lab.
Instead, Lou managed to join the high-level lab of Andr Lwoff, Jacques Monod and Franois Jacob at the Pasteur Institute. Those three men shared the Nobel Prize in Medicine in 1965, and in that period, Lou produced some of his most original scientific work. Collaborating with those giants, who rigorously explored big questions, branded Lou with the principle that defines him: Nothing less than excellence is good enough. What distinguishes Lou was that he has had no tolerance for compromise on excellence in science," said Calvin Stiller, a colleague of Lous for 50 years. "He literally snorts when he observes mediocrity; he senses bogus in a blink.
In 1953, ready to return to Canada, Lou joined the famed Connaught Laboratories in Toronto the city he has made his home, and where he began distinguishing himself through a parade of remarkable opportunities. In 1956, prominent Canadian histologist Arthur Ham appointed Lou to the Ontario Cancer Institute, where he established his independent research career with critical studies in the stem cell discovery and cancer research, and rapidly became the head of biological research. In 1968, he was invited to chair a new department in the University of Torontos medical school that incorporated genetics and immunology, two themes that had been missing in the faculty; this grew into a major research unit.
In 1978, Lou became head of genetics at SickKids hospital, again bringing in new talent and technologies, and setting the stage for world-class accomplishment in cloning genes like cystic fibrosis. And in 1984, while concurrently shaping a new research institute at the Baycrest geriatric centre for Joe Rotman, he was asked to develop a brand new research institute at Mount Sinai Hospital, with up-to-date molecular biology related to major diseases. He recruited stars like Tony Pawson, Janet Rossant and many more in the creation of the Lunenfeld-Tanenbaum Research Institute arguably the pinnacle of his achievements.
Story continues below advertisement
Lou deeply influenced research development at the University of Toronto and many Canadian institutions, as well as the national and provincial research funding agencies. But in building all these institutions, he was the one sought out to lead he never applied for any position.
His advice is constantly and widely sought and usually heeded. Its impossible for me to convey how much I learned from Lou through all those years and how much I owe him," said David Naylor, the former president of the University of Toronto. The advice came at lunches where the real menu was on Lous cue cards with its list of topics to be discussed or at other times in long, meticulously argued emails. Many Canadian leaders had the same experience.
Highly esteemed, Lou has received many awards and honorary degrees, including the Companion of the Order of Canada, the Canada Gairdner Wightman Award and induction to the Canadian Medical Hall of Fame. Internationally, he is one of few Canadians elected to both the Royal Society of the U.K. and the U.S. National Academy. He was truly one of the great medical builders of his day, a list that includes John Evans, Fraser Mustard and Jacques Genest, to name just a few.
Lou placed major emphasis on cultivating talent, creating intellectual descendants and finding outstanding leaders who have truly innovated and not many make his A-list. Lous science will never die, in that he has generated not only ideas, but offspring who will continue to carry out his work," said Montreal physician Phil Gold.
Lou can be described in many ways. Hes a driver of excellence and deeply committed to the idea that science can solve societal problems. Hes an institution, remembering how things happened and still worrying about where Canada stands as a nation in the world of science today. Hes a disturber of the status quo and a skilled science politician. Hes a passionate family man and, prompted by his playwright wife, he became an avid pursuer of culture in the arts and humanities, and the Elinore & Lou Siminovitch Prize in Theatre was developed by friends. Clearly, Lou could bridge the sciences and the arts.
And he is still the same old Lou. He goes to the office most days, surrounding himself with pictures of great art, mentors and family. He reads voraciously, absorbing daily newspapers, journals such as Science and Nature, as well as the books of the day. As he always says: I am still here.
Story continues below advertisement
As a centenarian who still stimulates and provokes, and who still yearns to build a better place, Lou deserves a public toast. We might not be able to do that right now, as we wrestle with the novel coronavirus and all its devastation. But as scientists fight the deadly infection, its a perfect time to remember the scientific foundations that this giant of Canadian medicine laid down. So on behalf of scientists from coast to coast to coast Canada has been good to me, he likes to say, and the same is true in reverse we raise a glass to you, Lou.
Keep your Opinions sharp and informed. Get the Opinion newsletter. Sign up today.
Go here to read the rest:
- Human vision restored by stem cell replacement in regenerative medicine breakthrough - Medical Xpress - November 12th, 2024
- Stem cells grown in space show super powers but theres a catch - Study Finds - November 12th, 2024
- Developing the Cell-Based Therapies of the Future - University of Miami - November 12th, 2024
- Japan performs world's first stem cell-treatment to restore vision - DrugsControl.org - November 12th, 2024
- HRT, Stem Cells, & Nitric Oxide: What This Longevity Expert Wants You To Know - mindbodygreen - November 10th, 2024
- Stem Cell Market Potential: Revolutionizing Regenerative Medicine and Therapeutics - openPR - November 10th, 2024
- Whats coming up at Cell & Gene Therapy International Europe 2024? - RegMedNet - November 10th, 2024
- The Team Stem Cell Medicine Ltd. - November 8th, 2024
- Stem Cell Medicine (SCM) Receives Israeli Government Funding for Gene ... - November 8th, 2024
- About Us Stem Cell Medicine Ltd. - November 8th, 2024
- Stem cell therapy improves mental, physical health in relapsing-remitting MS - Healio - November 8th, 2024
- Stem cells can tailor their role in gene therapy based on the underlying disease, study suggests - Medical Xpress - November 8th, 2024
- Researchers are one step closer to developing cell-based therapy for hypothyroidism - Medical Xpress - November 8th, 2024
- Sickle cell patient dies in Beam study of base editing therapy - BioPharma Dive - November 8th, 2024
- BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health - GlobeNewswire - November 8th, 2024
- Asymmetrex Presents the Impact of Differential Stem Cell Counting for Cultured Meat Production - EIN News - October 30th, 2024
- Minor cannabinoid shows promise in reducing anxiety - Drug Discovery News - October 30th, 2024
- Experts call for clear and concise regulation of exosome-based treatments - Medical Xpress - October 27th, 2024
- Stem cells: Arthritic vulture reunited with partner after jab - BBC.com - October 25th, 2024
- Cholesterol medications might be able to be repurposed for MS: Study - Multiple Sclerosis News Today - October 25th, 2024
- Cell and Gene Therapies Symposium Open to Public | Newswise - Newswise - October 25th, 2024
- Could This Protein Hold the Key to Reversing Brain Aging and Repairing Damage? - SciTechDaily - October 24th, 2024
- Arthritic vulture Bernard has his knee fixed in stem cell first - BBC.com - October 24th, 2024
- Findings in fruit flies could lead to new Parkinsons stem cell therapies - Parkinson's News Today - October 24th, 2024
- Stem Cell Therapy Market Size to Hit USD 48.89 Billion by 2033 - GlobeNewswire - October 22nd, 2024
- Japan mulls ways to boost cell, gene therapy approvals - BioWorld Online - October 22nd, 2024
- Meso Numismatics Changes Name to Regenerative Medical Technology Group and Ticker Symbol to RMTG - Newswire - October 22nd, 2024
- Medeze Group Awarded Frost & Sullivan's 2024 Southeast Asia Company of the Year for Delivering Highly Innovative Stem Cell and Longevity Solutions... - October 20th, 2024
- MexStemCells Clinic Partners with PlacidWay Medical Tourism to Expand Global Access to Regenerative Medicine - EIN News - October 20th, 2024
- Stem cell therapy reverses type 1 diabetes in world first - The Conversation - October 18th, 2024
- Factor Bioscience and Eterna Therapeutics Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology,... - October 18th, 2024
- Healing begins with research: Promising development program on stem cells in rare diseases - Pharmaceutical Technology - October 15th, 2024
- Chuck Murry | Stem cell science for healing the heart - University of Southern California - October 15th, 2024
- Stem cell therapy reverses type 1 diabetes in world first - Medical Xpress - October 15th, 2024
- AI Scaling Laws Poised To Transform Cell Replacement Therapy - Forbes - October 15th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 15th, 2024
- Stem cell discovery highlights importance of DNA methylation in cancer - Medical Xpress - October 11th, 2024
- $8.1M Grant Will Allow Researchers to Study the Ro | Newswise - Newswise - October 11th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 10th, 2024
- Improving Access to Cell and Gene Therapy in Pedia | Newswise - Newswise - October 10th, 2024
- Osteopore Partners with RxCell for Regenerative Medicine - TipRanks - October 10th, 2024
- USC's Keck School of Medicine partners with StemCardia to advance heart failure treatment - News-Medical.Net - October 10th, 2024
- Dr. Abdul Baker Pioneers Robotic Surgery and Stem Cell Therapy for Innovative Treatment & Recovery - openPR - October 8th, 2024
- How a Court Ruling Affects California Stem Cell Clinics That Use Unproven Therapies - KQED - October 8th, 2024
- Stem-cell therapy reverses type 1 diabetes in groundbreaking case study - Medical News Today - October 4th, 2024
- Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in... - October 4th, 2024
- Stem cell therapy to cure T1 diabetes? The Indian perspective - The Hindu - October 4th, 2024
- Stem cell therapy for osteoarthritis: Functional cartilage regeneration using 3d bioprinting technology - Open Access Government - October 4th, 2024
- Innovative Opportunities in Stem Cell Treatments: Insights from Genoma - Medical Tourism Magazine - October 4th, 2024
- BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - Yahoo Finance - October 4th, 2024
- Palmetto Stem Cell Therapy Advises on Streamlining the Regenerative Medicine Process for Joint Pain Relief - The Globe and Mail - October 2nd, 2024
- Woman's Own Stem Cells Appear to Reverse Her Type 1 Diabetes in First-Ever Procedure - Futurism - October 2nd, 2024
- Cell & Co. is Revolutionizing Regenerative Healthcare with Cutting-Edge Stem Cell Therapy in Malaysia - openPR - October 2nd, 2024
- Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience - MSN - October 2nd, 2024
- What are Exosomes, Growth Factors and Stem Cells? - NewBeauty Magazine - September 30th, 2024
- Treatment - National Heart, Lung, and Blood Institute - September 30th, 2024
- Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience - Medical Xpress - September 30th, 2024
- Stem Cell Therapy Market Overview, Share Analysis, Size And Forecast To 2033 - WhaTech - September 30th, 2024
- StemCardia Licenses Technologies for Heart Regeneration Developed at UW School of Medicine - Business Wire - September 30th, 2024
- Chinese Woman Becomes First In The World To Be Cured Of Type 1 Diabetes With Stem Cell Transplant - GreekCityTimes.com - September 30th, 2024
- Following Their Calling to Help Young Cancer Patients and Beyond - Stanford Children's Health - September 28th, 2024
- Greenberg Regenerative Medicine Celebrates Nearing 2 Years of Success with Pioneering VSEL Therapy - PR.com - September 28th, 2024
- Discovery clears hurdle in growing organs for transplants : Newsroom - UT Southwestern - September 26th, 2024
- Cell Therapy Market is Expected to Gain USD 60696.42 Million with a Growing CAGR of 19.20% by 2030 - openPR - September 25th, 2024
- Stem Cell Therapy Market To Reach USD 44 Billion By 2032 (Updated 2024) - Market.us Media - United States Market News - September 25th, 2024
- Doctors cured her sickle-cell disease. So why is she still in pain? - Nature.com - September 23rd, 2024
- The new frontier of luxury travel is a $44,000 course of stem cells and a longevity club stocked with IV stations - Fortune - September 23rd, 2024
- How stem cell and gene therapies are revolutionising healthcare - Express Healthcare - September 20th, 2024
- Exploring Regenerative Medicine and Its Impact on Modern Disease Management - Baltimore Post-Examiner - September 18th, 2024
- Stem Cell Therapy Market Dynamics: Size, Share, and Growth - openPR - September 16th, 2024
- Stem Cell Restore Review: Can It Boost Your Stem Cell Activity for Lasting Health? - Vashon-Maury Island Beachcomber - September 14th, 2024
- Stem Cell Therapy Market valued at USD 3.40 Billion by 2030 As Revealed In New Report - WhaTech - September 14th, 2024
- Stem Cell Manufacturing Market Projected to Witness Huge Growth by 2024-2031 As Revealed In New Report - WhaTech - September 14th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 12th, 2024
- Meso Numismatics Announces Cellgenics Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September - StockTitan - September 10th, 2024
- Meso Numismatics Announces Cellgenics Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September - Newswire - September 10th, 2024
- Breakthrough in blood stem cell development offers hope for leukemia and bone marrow failure - News-Medical.Net - September 8th, 2024
- Stem Cell Therapy Market Is Estimated To Reach $928.6 Million by 2031 | CAGR 16.2% - EIN News - September 8th, 2024
- USC researchers receive funding to develop next generation of intelligent biocomputers - EurekAlert - September 8th, 2024
- Risk Factors and Indications for Stem Cell Transplants in MDS - Targeted Oncology - September 6th, 2024
Recent Comments